Inocras to Present New Results from Agentic AI Framework for Scaling Cancer Whole-Genome Sequencing Interpretation at AMP 2026 – Business Wire

Inocras will present new results from its agentic AI framework designed to scale the interpretation of cancer whole-genome sequencing at the 2026 Association for Molecular Pathology (AMP) conference. The presentation will showcase the company’s progress in applying AI technology to genomic analysis and interpretation for cancer research and diagnostics.

Read Full Article →